Choong May Ling, Mimi – CEO, Health Sciences Authority (HSA), Singapore

Dr Choong May Ling, Mimi, CEO of Singapore’s Health Sciences Authority (HSA), one of the leading regulatory bodies in the Asia-Pacific region, outlines the impact of Singapore’s status as a life sciences hub, the launch of novel priority review avenues, and how the authority is adjusting to the new industry paradigm that data and AI is helping create.  
Collaboration has always been critical, and our connectivity has enabled us to build strong partnerships to achieve mutually beneficial outcomes
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report